Advancing clinical trials for rare renal cell carcinoma subtypes: Consensus statements from the I...
September 13, 2026
Share
Advancing clinical trials for rare renal cell carcinoma subtypes: Consensus statements from the International Kidney Cancer Symposium North America 2025 think tank.